HUMAN PLACENTAL LIPIDS
HUMAN PLACENTAL LIPIDS is a cosmetic ingredient classified as Hair Conditioning.. It is regulated in 1 market including South Korea.
Also Known As
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for HUMAN PLACENTAL LIPIDS in European Union, United Kingdom.
AmericasNo restrictions
No specific restrictions for HUMAN PLACENTAL LIPIDS in United States, California, Maryland, Washington, Canada, Brazil.
East Asia & Oceania1 regulation
- Chemical name
- Human Placental Lipids
Source: MFDS Korea Cosmetics Regulation
ASEANNo restrictions
No specific restrictions for HUMAN PLACENTAL LIPIDS in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for HUMAN PLACENTAL LIPIDS in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for HUMAN PLACENTAL LIPIDS in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is HUMAN PLACENTAL LIPIDS banned in any country?
Yes, HUMAN PLACENTAL LIPIDS is banned in South Korea. Always check current regulations before formulating products for these markets.
What are the restrictions on HUMAN PLACENTAL LIPIDS in cosmetics?
HUMAN PLACENTAL LIPIDS is banned in South Korea and has no specific restrictions in other tracked markets.
Can I use HUMAN PLACENTAL LIPIDS in cosmetics?
HUMAN PLACENTAL LIPIDS is regulated in 1 market. It is banned in South Korea. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.
Screen HUMAN PLACENTAL LIPIDS with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.